Manufacture

Where is this variability come from? It's time for Gene and Eva to investigate!

David Walker discusses the threat of bioterrorism and the importance of basic research.

Emergent Biosolutions, has become a multinational biopharma company, despite working in some difficult therapeutic areas including biodefense.

A single vector vaccine has been developed that could offer protection against tularemia, anthrax, plague and melioidosis.

How can we prepare ourselves for the threats of emerging infectious disease?

Why salt-tolerant resins make for “happier” biomolecules with better binding.

Innovation is being boosted in manufacturing and purification techniques.

Disposable technology has found its place in the biopharma industry, but where does the story go from here?

How to develop a robust and consistent bioprocess.

Meet the companies and researchers protecting us from bioterrorists who plan to harness the destructive power of infectious diseases.